The European Union encompasses 30 outermost and overseas countries and territories (OCTs). Despite a recent increasing activity of renal transplantation in these territories, many patients still undergo transplantation in continental Europe, with follow-up care coordinated between health professionals from both their transplant center and their home region. Each territory has its unique infectious epidemiology which must be known to ensure appropriate care for kidney transplant recipients (KTRs).

This paper proposes a pragmatic approach to optimize pre-transplant check-up and to provide an overview of the specific epidemiological features of each region. It offers practical algorithms to help practitioners in managing infected KTR living in these territories. This work advocates for increased collaborative research among European OCTs.

Endemic in over 45 countries globally, recent reports of locally acquired melioidosis in novel geographical areas, such as the Southern US, have highlighted the expanding geographical range of Burkholderia pseudomallei. Climate change and severe weather events have been linked to an increase in cases of melioidosis, which follows environmental exposure to the bacterium. Healthcare professionals should be aware of the possibility of the disease, with its diverse and often delayed presentations, even in areas not previously known to have risk. Over 200 cases of travel-associated melioidosis have been reported in the literature, highlighting the need to consider this disease in non-endemic areas, as diagnostic delays of up to 18 months have been identified. The review updates the global epidemiology of melioidosis, focusing on new geographical areas where cases have been diagnosed and imported cases, unusual clinical presentations and co-infections, and less frequent modes of transmission (laboratory exposures and the risk of acquisition due to imported infected animals and contaminated products).

Melioidosis is uncommon but endemic in Southeast Asia and parts of Northern Australia. Cerebral melioidosis is rare but can be spread through several routes, such as hematogenous spreading or the direct inoculation of organisms from wound contamination with soil. It can cause devastating sequelae if the treatment is delayed. However, with early and adequate treatment, patients can recover and have a good quality of life.

A 62-year-old diabetic male presented with epilepsy 2 months after a head injury. A computed tomography scan revealed an abscess extending from the subgaleal layer to the subdural with osteomyelitis. A craniotomy was performed to remove the abscess. Melioidosis was identified from pus culture. Intravenous meropenem with Bactrim was started, followed by oral doxycycline and bactrim. The patient recovered with no seizure episodes. This patient showed a rare but straightforward infection from direct inoculation in a wound contaminated with soil. Incubation time could be up to 2 months. The infection originates from previously lacerated scalp tissue and invades the skull, causing osteomyelitis and epidural abscess. Prompt treatment brings a good outcome. In patients with risk factors and a suspicious history, broad-spectrum antibiotics should be initiated after removal of the abscess.

Melioidosis is still endemic in Thailand. Doctors should be aware of this organism in patients with high-risk factors or travelers who have just returned from an endemic area. Patients should be treated early with an adequate dose and duration of anti-melioidosis.

Melioidosis, an infectious disease caused by Burkholderia pseudomallei (B. pseudomallei), occurs endemically in Southeast Asia and Northern Australia and is a serious opportunistic infection associated with a high mortality rate.

A 58-year-old woman presented with scattered erythema on the skin of her limbs, followed by fever and seizures. B. pseudomallei was isolated successively from the patient's urine, blood, and pus. Magnetic resonance imaging showed abscess formation involving the right forehead and the right frontal region. Subsequently, abscess resection and drainage were performed. The patient showed no signs of relapse after 4 months of follow-up visits post-treatment.

We present here a unique case of multi-systemic melioidosis that occurs in non-endemic regions in a patient who had no recent travel history. Hence, it is critical to enhance awareness of melioidosis in non-endemic regions.